Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Germany / NCT05246527
Recruiting Not applicable

Acute Effects of Physical Exercise in Patients with Borderline Personality Disorder

NCT05246527 · tracked via the Priya Life Science Germany tracker
Phase
Not applicable
Started
2022-02-08
Last updated
2024-12-11

Condition(s) studied

Borderline Personality Disorder

Investigational drug(s) / intervention(s)

Physical ExerciseControl Intervention

Physical Exercise: 30 min of cycling on an ergometer, moderate or high intensity

Control Intervention: 30 min of watching a movie

Study summary

The aim of the proposed project is to investigate the effects of a single session of physical exercise on stress regulation, cognitive and emotional functioning, and associated neurophysiological processes (saliva and blood samples) in patients with borderline personality disorder. A further aim is to identify the optimal exercise intensity (moderate vs. high intensity). The investigatiors expect that acute exercise will lead to positive effects on behavioral and biomarker level.

Eligibility

Sex
ALL
Min age
18 Years
Max age
50 Years
Healthy volunteers
Accepted
Inclusion Criteria: * estimated verbal intelligence quotient \>80 (MWT-B; Lehrl 2005) * patients: diagnosis of borderline personality disorder according to DSM-5 Exclusion Criteria: * neurological disorders * health conditions interfering with exercise safety, e.g. coronary heart disease * visual impairments that may interfere with performance of the cognitive tasks * endocrine disorders, e.g. hyperthyreosis or diabetes mellitus; * following psychiatric disorders: psychosis or affective disorders with psychotic symptoms, schizophrenia, substance abuse or dependence, autism spectrum disorders, anorexia nervosa; * healthy controls: BPD, intake of psychotropic drugs

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University Hospital Bonn Bonn North Rhine-Westphalia Recruiting

More University Hospital, Bonn trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05246527 on ClinicalTrials.gov ↗ ← All trials in Germany